Cargando…
The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
IMPORTANCE: Without third-party insurance, access to marketed drugs is limited to those who can afford to pay. We examined this phenomenon in the context of anticoagulation for patients with nonvalvular atrial fibrillation (NVAF). OBJECTIVE: To determine whether, among older Ontarians receiving anti...
Autores principales: | Sholzberg, Michelle, Gomes, Tara, Juurlink, David N., Yao, Zhan, Mamdani, Muhammad M., Laupacis, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767939/ https://www.ncbi.nlm.nih.gov/pubmed/26914450 http://dx.doi.org/10.1371/journal.pone.0149142 |
Ejemplares similares
-
Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017) -
Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
por: Antoniou, Tony, et al.
Publicado: (2015) -
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014) -
Reconnaître, traiter et signaler les cas de thrombocytopénie immunitaire thrombotique induite par un vaccin
por: Sholzberg, Michelle, et al.
Publicado: (2021) -
Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia
por: Sholzberg, Michelle, et al.
Publicado: (2021)